These results indicate that early activation of the IRF1-HLA pathway in critically ill sepsis patients may play a prophylactic role in reducing ARDS susceptibility and mortality; however, whether preventive intervention would benefit all sepsis patients remains unclear. This evidence concerns the gene IRF1 and acute respiratory distress syndrome.